
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current EXEL market cap is 12.14B. The company's latest EPS is USD 1.9114 and P/E is 23.28.
Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Jan 2025 | Apr 2025 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 425.23M | 637.18M | 539.54M | 566.76M | 555.45M |
Operating Income | 29.46M | 275.87M | 187.75M | 163.21M | 186.86M |
Net Income | 37.32M | 226.12M | 117.97M | 139.86M | 159.62M |
Year End January 02 2025 | 2021 | 2021 | 2022 | 2023 | 2025 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 987.54M | 1.43B | 1.61B | 1.83B | 2.17B |
Operating Income | 110.06M | 286.67M | 201.48M | 170.89M | 656.29M |
Net Income | 111.78M | 231.06M | 182.28M | 207.77M | 521.27M |
Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Jan 2025 | Apr 2025 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 2.8B | 2.77B | 2.96B | 2.95B | 2.84B |
Total Liabilities | 675.74M | 653.39M | 684.86M | 703.49M | 706.22M |
Total Equity | 2.13B | 2.12B | 2.28B | 2.24B | 2.13B |
Year End January 02 2025 | 2021 | 2021 | 2022 | 2023 | 2025 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 2.14B | 2.62B | 3.07B | 2.94B | 2.95B |
Total Liabilities | 258.22M | 405.62M | 583.06M | 678.45M | 703.49M |
Total Equity | 1.88B | 2.21B | 2.49B | 2.26B | 2.24B |
Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Jan 2025 | Apr 2025 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 68.82M | 188.37M | 459.71M | 699.97M | 211.44M |
Investing | 111.79M | 193.57M | -23.58M | -116.78M | 49.76M |
Financing | -184.05M | -446.47M | -440.77M | -628.81M | -294.82M |
Year End January 02 2025 | 2021 | 2021 | 2022 | 2023 | 2025 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 208.98M | 400.8M | 362.61M | 333.32M | 699.97M |
Investing | -131.22M | -42.88M | -524.41M | -26.96M | -116.78M |
Financing | -25.13M | -14.8M | 586k | -546.05M | -628.81M |
Market Cap | 12.14B |
Price to Earnings Ratio | 23.28 |
Price to Sales Ratio | 5.6 |
Price to Cash Ratio | 55.83 |
Price to Book Ratio | 5.41 |
Dividend Yield | - |
Shares Outstanding | 272.71M |
Average Volume (1 week) | 1.93M |
Average Volume (1 Month) | 3.73M |
52 Week Change | 98.22% |
52 Week High | 49.62 |
52 Week Low | 22.20 |
Spread (Intraday) | 0.49 (1.09%) |
Company Name | Exelixis Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.exelixis.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions